v3.26.1
COMMITMENTS
6 Months Ended
Jun. 30, 2026
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS

NOTE 12COMMITMENTS

 

(1) Contract Manufacturing Agreement

 

Milestone Scientific has informal arrangements with third-party manufacturers of the STA devices and epidural instruments pursuant to which they manufacture these products under specific purchase orders but without any long-term contract or minimum purchase commitment. The Company has a purchase commitment for the delivery of 1,650 STA instruments as of June 30, 2026. As of June 30, 2026 and December 31, 2025, the purchase order commitment was approximately 871,000 respectively, and approximately $1.4 million was paid and reported in advance on contracts in the unaudited condensed consolidated balance sheet. The Company also had advances on contracts of approximately $364,000 related to materials for future purchase orders for the manufacture of its next-generation dental instrument.

 

The advances in contracts represent funding for future epidural instruments and epidural replacement parts. As of June 30, 2026 and December 31, 2025, the Company also has advances on an open purchase order for long lead items for a future purchase order for the manufacturing of Epidural instruments of approximately $34,000, respectively.

 

(2) Operating Leases

 

The Company identified and assessed the following significant assumptions in recognizing its right-of-use assets and corresponding lease liabilities:

 

  As the Company’s leases do not provide an implicit rate, the Company estimated the incremental borrowing rate in calculating the present value of the lease payments. The Company has utilized its incremental borrowing rate based on the long-term borrowing costs of comparable companies in the Medical Device industry.
  Since the Company elected to account for each lease component and its associated non-lease components as a single combined lease component, all contract consideration was allocated to the combined lease component.
  The expected lease terms include non-cancellable lease periods. Renewal option periods are not included in the determination of the lease terms as they were not reasonably certain to be exercised.

 

The components of lease expense were as follows:

 

 

   June 30, 2026   June 30, 2025   June 30, 2026   June 30, 2025 
   Three months ended   Six months ended 
   June 30, 2026   June 30, 2025   June 30, 2026   June 30, 2025 
Cash paid for operating lease liabilities  $31,882   $31,882   $31,882   $63,764 
Cash paid for finance lease liabilities   3,417    3,417    3,417    6,834 
Weighted Average Remaining Lease Term                    
Finance leases (years)              3.27 years      4.50 years  
Operating leases (years)              0.75 years      1.75 years  
Weighted-average discount rate – operating leases             9.20%   9.20%
Weighted-average discount rate – finance leases             9.20%   9.20%